Kinetics of daunorubicin transport by P‐glycoprotein of intact cancer cells
- 1 July 1992
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 207 (2) , 567-579
Abstract
Drug permeation across the plasma membrane of multidrug-resistant cells depends on the kinetics of the P-glycoprotein-mediated pump activity as well as on the passive permeation of the drug. We here demonstrate a method to characterize kinetically the pump in intact cells. To this purpose, we examined the membrane-transport properties of daunorubicin in various sensitive cancer cell lines and in their multidrug resistant (MDR) counterparts. First, we determined the passive permeability coefficient for daunorubicin. Then, using a flow-through system, the drug flux into the cell was measured after inhibition of the P-glycoprotein-mediated efflux pump. Combining the two results allowed us to calculate the intracellular free concentration of the drug. In the steady-state, the pump rate must equal the net rate of passive diffusion of the drug and, therefore, the same experiments gave us the pumping rate of daunorubicin. These experiments were then repeated at various extracellular drug concentrations. By plotting the pumping rate versus the intracellular drug concentration, we then characterized the P-glycoprotein kinetically. Four independent methods were used to measure the passive permeability coefficient for the cell line A2780. Similar values were obtained. Maximal pump rates (Vmax) showed a good correlation with the amount of P-glycoprotein in the cell lines used. We obtained saturation curves for the variation of the pump rates with the intracellular daunorubicin concentrations. These curves were typical for positive cooperativity, which provides evidence that at least two binding sites for daunorubicin are present on the active transport system of daunorubicin. The apparent Km values for P-glycoprotein-mediated transport, the intracellular free cytosolic daunorubicin concentrations at half-maximal velocity for the cell lines used, were approximately 1.5 microM. Except for the cell lines with the highest amount of P-glycoprotein, the passive efflux rate of daunorubicin proved to be a substantial part of the total daunorubicin efflux rate for the cell lines used. In cell lines with relatively low levels of P-glycoprotein, passive daunorubicin efflux was even the main route of daunorubicin transport from the cells, determining the intracellular steady-state concentrations of daunorubicin.Keywords
This publication has 47 references indexed in Scilit:
- Probing daunorubicin accumulation defects in non‐P‐glycoprotein expressing multidrug‐resistant cell lines using digitoninInternational Journal of Cancer, 1992
- Cellular daunomycin fluorescence in multidrug resistant 2780AD cells and its relation to cellular drug localisationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradientBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- A model for computer simulation of P-glycoprotein and transmembrane ΔpH-mediated anthracycline transport in multidrug-resistant tumor cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Transepithelial transport of vinblastine by kidney-derived cell lines. Application of a new kinetic model to estimate in situ Km of the pumpBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Fast kinetic analysis of drug transport in multidrug resistant cells using a pulsed quench-flow apparatusBiochemical and Biophysical Research Communications, 1990
- Doxorubicin resistance in P388 leukemia—evidence for reduced drug influxInternational Journal of Cancer, 1989
- Increased Cytosolic pH in Multidrug-Resistant Human Lung Tumor Cells: Effect of VerapamilJNCI: Journal of the National Cancer Institute, 1989
- A Hypothesis Concerning the Effect of Changes in Scheduling upon the Cardiotoxicity of AdriamycinOncology, 1983
- A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells.Journal of General Physiology, 1981